Interventional Oncology

SIR Vascular Huddle Symposium

Provocative IO Thoughts for Liver Cancer

Coordinator(s)

• 

  Nima Kokabi, MD

  Associate Professor of Radiology
  University of North Carolina - Chapel Hill, United States
• 

  Laura Crocetti, MD, PhD (she/her/hers)

  Associate Professor
  Università di Pisa, Italy

Presentations:

• 3:00 PM – 3:12 PM CT

  Where is the role of TACE for HCC in the era of Y90 TARE popularity
  

  Speaker: Nariman Nezami, MD (he/him/his) – Georgetown University Medical Center

  Speaker: Julius Chapiro, MD, PhD – Yale Interventional Oncology Research Lab
• 3:12 PM – 3:24 PM CT

  Is Y90 dead for metastatic colorectal cancer?
  

  Speaker: Rony Avritscher, MD – MD Anderson Cancer Center

  Speaker: Ripal Gandhi, MD, FSIR – Miami Cardiac & Vascular Institute, Miami Cancer Institute
• 3:24 PM – 3:36 PM CT

  Robot Assisted Percutaneous Ablation: Is it worth the cost and trouble?
  

  Speaker: Govindarajan Narayanan, MD, FSIR – Miami Cardiac & Vascular Institute

  Speaker: Suvranu Ganguli, MD (he/him/his) – Boston Medical Center/Boston University School of Medicine
• 3:36 PM – 3:48 PM CT

  Do we really need histotripsy for liver cancers?
  

  Speaker: Timothy J. Ziemlewicz, MD – University of Wisconsin Hospital and Clinics

  Speaker: Siddharth Padia, MD – David Geffen School of Medicine at UCLA
• 3:48 PM – 4:00 PM CT

  Q&A